Two Sigma Advisers’s VistaGen Therapeutics VTGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.7K | Buy |
25,832
+15,100
| +141% | +$30.2K | ﹤0.01% | 2251 |
|
|
2025
Q1 | $26.8K | Sell |
10,732
-1,300
| -11% | -$3.25K | ﹤0.01% | 2346 |
|
|
2024
Q4 | $35.5K | Buy |
+12,032
| New | +$35.5K | ﹤0.01% | 2307 |
|
|
2023
Q1 | – | Sell |
-1,117
| Closed | -$3.45K | – | 2764 |
|
|
2022
Q4 | $3.45K | Sell |
1,117
-6,696
| -86% | -$20.7K | ﹤0.01% | 2483 |
|
|
2022
Q3 | $36K | Buy |
+7,813
| New | +$36K | ﹤0.01% | 2398 |
|
|
2022
Q2 | – | Sell |
-13,667
| Closed | -$508K | – | 2887 |
|
|
2022
Q1 | $508K | Sell |
13,667
-19,626
| -59% | -$729K | ﹤0.01% | 1978 |
|
|
2021
Q4 | $1.95M | Sell |
33,293
-3,690
| -10% | -$216K | ﹤0.01% | 1215 |
|
|
2021
Q3 | $3.04M | Buy |
36,983
+15,950
| +76% | +$1.31M | 0.01% | 1029 |
|
|
2021
Q2 | $1.99M | Sell |
21,033
-2,490
| -11% | -$235K | 0.01% | 1303 |
|
|
2021
Q1 | $1.5M | Buy |
23,523
+19,580
| +497% | +$1.25M | ﹤0.01% | 1416 |
|
|
2020
Q4 | $230K | Buy |
3,943
+2,983
| +311% | +$174K | ﹤0.01% | 2119 |
|
|
2020
Q3 | $20K | Buy |
+960
| New | +$20K | ﹤0.01% | 2361 |
|